Type 2 diabetes, obstructive sleep aponea and obesity
Ongoing
-
Adelaide SA | Goolwa SA
Effect of a new medication on participants without type 2 diabetes who have obesity and OSA.
- Closed to screening
- Monthly self-administered injections (similar to Epipen)
This study will finish soon
- BMI > 27 kg/m²
- Type 2 diabetes
- Obstructive sleep apnoea (OSA)
Outpatient Visit
- Clinic visits every 2 months
- Annual sleep study (free for participants)
Payment / Remuneration
- Reimbursed for travel